IDiyas

For the Inventor, By the Inventor

Cardiff-by-the-Sea, CA, United States of America

Robert W Chesnut

USPTO Granted Patents = 15 



Average Co-Inventor Count = 5.4

ph-index = 9

Forward Citations = 294(Granted Patents)


Location History:

  • Cardiff, CA (US) (2000)
  • Cardiff by the Sea, CA (US) (2001 - 2018)

Company Filing History:

goldMedal7 out of 17 
 
Epimmune Inc.
 patents
silverMedal3 out of 6 
 
Pharmexa Inc.
 patents
bronzeMedal2 out of 2 
 
Ose Pharma International Sa
 patents
4. 2 out of 3 
 
Genimmune N.v.
 patents
5. 1 out of 1 
 
Biotech Synergy, Inc.
 patent
6. 1 out of 34 
 
Cytel Corporation
 patents
where one patent can have more than one assignee

Years Active: 2000-2018

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 9913884 - HLA-A2 tumor associated antigen peptides and compositions (2018-03-13),
2. 9394350 - HLA-A2 tumor associated antigen peptides and compositions (2016-07-19),
3. 9340577 - HLA binding motifs and peptides and their uses (2016-05-17),
4. 8007810 - HLA-A2 tumor associated antigen peptides and compositions (2011-08-30),
5. 7888472 - Optimized multi-epitope constructs and uses thereof (2011-02-15),
6. 7611713 - Inducing cellular immune responses to hepatitis B virus using peptide compositions (2009-11-03),
7. 7572882 - Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions (2009-08-11),
8. 7507803 - Optimized multi-epitope constructs and uses thereof (2009-03-24),
9. 7462354 - Method and system for optimizing minigenes and peptides encoded thereby (2008-12-09),
10. 7026443 - Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions (2006-04-11),
11. 6689363 - Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions (2004-02-10),
12. 6602510 - HLA class I A2 tumor associated antigen peptides and vaccine compositions (2003-08-05),
13. 6534482 - Expression vectors for stimulating an immune response and methods of using the same (2003-03-18),
14. 6322789 - HLA-restricted hepatitis B virus CTL epitopes (2001-11-27),
15. 6033667 - Method for detecting the presence of P-selectin (2000-03-07),

Title: Innovator Spotlight: Robert W. Chesnut

Introduction: Robert W. Chesnut, a renowned inventor based in Cardiff-by-the-Sea, California, has made significant contributions to the field of immunology through his innovative work. With a remarkable portfolio of 14 patents, Chesnut is recognized for his advancements in cancer research, particularly concerning tumor-associated antigens.

Latest Patents: Among his latest achievements are his patents on HLA-A2 tumor-associated antigen peptides and compositions. These patents focus on peptides or compositions that include at least one HLA-A2 epitope or analog from various sources such as CEA, HER2/neu, MAGE2, MAGE3, or p53. His work exemplifies a commitment to advancing therapeutic options in the fight against cancer.

Career Highlights: Robert W. Chesnut has held influential roles in notable companies, including Epimmune Inc. and Pharmexa Inc. His experience in these organizations has allowed him to translate his innovative ideas into practical applications, furthering the understanding and treatment of cancer.

Collaborations: Throughout his career, Chesnut has collaborated with distinguished professionals in the field, such as Alessandro D. Sette and Brian D. Livingston. These collaborations highlight the importance of teamwork in driving forward scientific discovery and innovation.

Conclusion: Robert W. Chesnut's contributions to immunology and cancer research through his innovative patents and collaborations exemplify the vital role inventors play in advancing healthcare. His ongoing dedication to discovery continues to inspire future generations in the realm of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…